DUBLIN--(BUSINESS WIRE)--The "Microsurgery Market Size, Share, Trends, By Procedure, By End-use, By Application, By Equipment, and By Region Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
The global microsurgery market size is expected to reach USD 3.38 Billion in 2030 and register a revenue CAGR of 6.9% over the forecast period, according to the latest report.
Companies Mentioned
- ZEISS International
- Haag-Streit Surgical
- Novartis AG
- Beaver-Visitec International Inc.
- Global Surgical Corporation
- Olympus Corporation
- Scanlan International
- B. Braun Melsungen AG
- Stille
- Topcon Corporation
Increasing healthcare expenditure, growing occurrence of chronic diseases, and the rising number of organ transplantations are some of the major factors driving market growth. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in 2017, around 30 million people in the U.S. were affected by kidney disease.
Microsurgery is a subspecialty of surgery that uses an operative microscope for the treatment of problems. It is generally performed to repair nerves or blood vessels. The rising prevalence of chronic diseases and the increasing number of organ transplantations are some of the major factors driving market growth. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in 2017, around 30 million people in the U.S. were affected by kidney disease.
The rising number of mergers and acquisitions among key market players is expected to drive market growth over the forecast period.
Some Key Highlights From the Report:
- In November 2020, MMI Micro launched OpticsPro, a new microsurgery platform that offers a comprehensive suite of solutions for cataract and refractive surgeons. The OpticsPro platform includes the company's proprietary technologies: the iQ-Vue microscope, which is an advanced imaging system that provides real-time video of the eye during surgery; and the OptiProbe, which is a handheld, miniature microscope that enables surgeons to perform microsurgery with greater control and precision.
- Transplantation segment accounted for largest revenue share in the global market in 2020 due to rising number of organ transplantation procedures and increasing number of transplantation centers across the globe. According to United Network for Organ Sharing (UNOS), in 2020, around 34,768 organ transplants were performed in the U.S. In addition, as per UNOS, every 10 minutes someone is added to the national transplant waiting list and an average of 22 people die each day while waiting for a transplant.
- The oncology segment is projected to register fastest growth in the global market during the forecast period due to rising prevalence of cancer and increasing number of cancer surgeries. According to the National Cancer Institute, in 2020, an estimated 1,806,590 new cancer cases were diagnosed and 606,520 people died from the disease in the U.S. Moreover, as per the World Health Organization (WHO), in 2018, around 18.1 million new cancer cases and 9.6 million cancer deaths were recorded globally.
- The hospitals segment is expected to account for largest revenue share in the global market during the forecast period due to large number of organ transplantation procedures conducted in hospitals. According to the American Hospital Association (AHA), in 2019, there were around 5,534 community hospitals in the U.S.
- North America accounted for largest revenue share in the global market in 2020 due to large number of organ transplantation procedures and increasing prevalence of cancer in the region. According to the United Network for Organ Sharing (UNOS), in 2020, around 34,768 organ transplants were performed in the U.S. Moreover, as per the National Cancer Institute, in 2020, an estimated 1,806,590 new cancer cases were diagnosed and 606,520 people died from the disease in the U.S.
- Europe is expected to witness significant growth in the global market during the forecast period due to presence of large number of transplantation centers and increasing prevalence of cancer in the region. According to Eurotransplant, in 2019, around 30,168 organ transplants were performed across Europe. Moreover, as per the World Cancer Research Fund International, in 2018, around 3,162,345 new cancer cases and 1,752,887 cancer deaths were recorded in Europe.
For the purpose of this report, the author has segmented the microsurgery market based on procedure, application, end-use, and region:
Procedure Outlook (Revenue, USD Billion; 2019-2030)
- Free Flap Tissue Transfer
- Suture and Grafting
- Wound Reconstruction
- Transplantation
- Nerve Repair
End-use Outlook (Revenue, USD Billion; 2019-2030)
- Hospitals and Clinics
- Academic & Government Research Institutions
- Ambulatory Surgical Centers
Application Outlook (Revenue, USD Billion; 2019-2030)
- General Surgery
- Oncology
- Neurology
- Ophthalmology
- Orthopedic Surgery
- Plastic & Reconstructive Surgery
- Gynecology Surgery
- Others
Equipment Outlook (Revenue, USD Billion; 2019-2030)
- Operating Microscopes
- Microsurgery Forceps & Needle Holders
- Microsutures
Regional Outlook (Revenue, USD Billion; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Israel
- Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/14hdcr
